Atlas Trials

Safety Study of Sublingual Immunotherapy Tablets of House Dust Mite Allergen Extracts

Clinical trial NCT01608243 · COMPLETED

Trial details

NCT number
NCT01608243
Sponsor
Stallergenes Greer
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
AsthmaHouse Dust Mite Allergy
Start date
2012-05-01
Primary completion
2014-06-01
Enrollment
94

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.